Summary
Long title
A Bill to require the Secretary of State to take steps to secure licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
Latest publications
Bill
Resources for this event
Order Paper
View the details for this event in the Daily Order Paper
Commons Library research briefings
Find the research briefing for this event
Bill details
Get more information about Off-patent Drugs Bill
Hansard record for this event
Hansard entry
Read the official report and Member contributions for this event
Voting record for this event
Votes in Parliament
Find vote results for this event
Links
Bill webpage